LEADER 01320nam  2200373Ia 450 
001 9910696916003321
005 20230902161734.0
035   $a(CKB)5470000002383735
035   $a(OCoLC)565894701
035   $a(EXLCZ)995470000002383735
100   $a20100322d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eincorporation of physical-chemical identifiers into solid oral dosage form drug products for anticounterfeiting
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2009]
215   $a1 electronic resource (8 pages)
300   $a"Draft guidance."
300   $a"CMC."
300   $a"July 2009."
517   $aGuidance for industry 
606   $aProduct counterfeiting$zUnited States$xPrevention
606   $aSolid dosage forms$zUnited States
615  0$aProduct counterfeiting$xPrevention.
615  0$aSolid dosage forms
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696916003321
996   $aGuidance for industry$93434577
997   $aUNINA